Atlas Trials

Effect of Vildagliptin Versus Dapagliflozin as Add on Therapy to Metformin on Cardiovascular Risk Factors

Clinical trial NCT07077525 · COMPLETED

Trial details

NCT number
NCT07077525
Sponsor
Al-Azhar University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2023-06-01
Primary completion
2024-08-10
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.